✨
AI Summary & Key Takeaways
AI Insight⚡ TL;DR(Too Long; Didn't Read)
The first carbapenem resistant Klebsiella pneumoniae strain having OXA-48 enzyme isolated from the blood culture of an acute myelocytic leukaemia patient is presented.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:The first carbapenem resistant Klebsiella pneumoniae strain having OXA-48 enzyme isolated from the blood culture of an acute myelocytic leukaemia patient is presented.
📊
Key Findings & Data:The first carbapenem resistant Klebsiella pneumoniae strain having OXA-48 enzyme isolated from the blood culture of an acute myelocytic leukaemia patient is presented.
💡
Conclusion & Impact:The first carbapenem resistant Klebsiella pneumoniae strain having OXA-48 enzyme isolated from the blood culture of an acute myelocytic leukaemia patient is presented.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
The first carbapenem resistant Klebsiella pneumoniae strain having OXA-48 enzyme isolated from the blood culture of an acute myelocytic leukaemia patient is presented.
Özet
Akut Myelositer Lösemili (AML) bir hastanın kan kültüründen Ege Bölgesi'nde ilk kez izole edilen OXA-48 enzimi içeren karbapenem dirençli Klebsiella pneumoniae kökeni bildirilmiştir.
🔖
Cite This Article
YILMAZ, M., ŞAMLIOĞLU, P., ÇİLLİ, F., DİVANOĞLU, Y., MİDİLLİ, K., TÜNGER, A., AYDEMİR, Ş. (2022). The first carbapenem-resistant Klebsiella pneumoniae strain in the Aegean region, Turkey. İnfeksiyon Dergisi, Cilt: 19 - Sayı: 2, 249–251. https://ajindex.com/articles/651817